As a key receptor in TGF-beta signaling, TGFBR2 loss-of-function mutations can shift TGF-beta from a tumor-suppressive to a pro-oncogenic role, promoting immune evasion and metastasis. This evidence concerns the gene TGFBR2 and neoplasm.